High-dispersity composition of low-dose drugs and preparation method of high-dispersity composition

A low-dose, composition technology, applied in the low-dose pharmaceutical composition and its preparation, the low-dose pharmaceutical composition and its preparation field, can solve the problems such as the application of twin-screw extrusion technology that has not been reported yet

Active Publication Date: 2018-09-14
NANJING HERON PHARM CO LTD
View PDF5 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The application of twin-screw extrusion technology in the preparation of low-dose drug compositions and formulations has not been reported in the prior art

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • High-dispersity composition of low-dose drugs and preparation method of high-dispersity composition
  • High-dispersity composition of low-dose drugs and preparation method of high-dispersity composition
  • High-dispersity composition of low-dose drugs and preparation method of high-dispersity composition

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0083] Preparation of Embodiment 1 Alfacalcidol Tablets, Small Test Process

[0084] 1. Prescription

[0085]

[0086] 2. The preparation method specifically comprises the following steps:

[0087] 1) dissolving the crude drug alfacalcidol in absolute ethanol to make a solution;

[0088] 2) Weigh the prescribed amount of anhydrous lactose, povidone, and propyl gallate in a wet mixing granulator, and the mixing time is greater than or equal to 5 minutes to make dry powder;

[0089] 3) Add the dry powder obtained in the above step 2) into the solid feeder, and after the solution obtained in the above step 1) is connected to the extruder through a low-pulse peristaltic pump, control the granulation temperature of the twin-screw extruder at 20-25 Between ℃, adjust the feeding speed of dry powder to 1.0-2.0kg / hr, the speed of peristaltic pump to 2rpm-4rpm, and the speed of twin-screw to 100rpm-200rpm, and the above-mentioned dry powder and solution enter the twin-screw extrude...

Embodiment 2

[0093] Example 2 Preparation of Alfacalcidol Tablets, Pilot Test Process

[0094] 1. Prescription

[0095]

[0096] 2. The preparation method specifically comprises the following steps:

[0097] 1) dissolving the crude drug alfacalcidol in absolute ethanol to make a solution;

[0098] 2) Weigh the prescribed amount of anhydrous lactose, povidone, and propyl gallate in a wet mixing granulator, and the mixing time is greater than or equal to 5 minutes to make dry powder;

[0099] 3) Add the dry powder obtained in the above step 2) into the solid feeder, and after the solution obtained in the above step 1) is connected to the extruder through a low-pulse peristaltic pump, control the granulation temperature of the twin-screw extruder at 20-25 Between ℃, adjust the feeding speed of dry powder to 2.0-3.0kg / hr, the speed of peristaltic pump to 4rpm-8rpm, and the speed of twin-screw to 300rpm-400rpm, and the above-mentioned dry powder and solution enter the twin-screw extruder w...

Embodiment 3 comparative Embodiment 1

[0103] Example 3 Comparative Example 1 CN104739793A discloses a kind of alfacalcidol tablet and its preparation method, adopts traditional wet granulation, according to the preparation method of Example 1 in the text, uses the same prescription of the present invention, obtains comparative example 1 Alpha tablets. The process description is as follows: Weigh the raw and auxiliary materials of the prescription amount, pass through 80 mesh sieves respectively for standby; configure the adhesive solution; Soft material; after granulating with a 40-mesh sieve, dry at 50°C for 30 minutes, pass through a 20-mesh sieve for granulation, add magnesium stearate, mix evenly, and press into tablets.

[0104] Example 4 Comparative Example 2 CN1196677A discloses a preparation method of a very low-dose solid dosage form of medicine, using high-speed shear mixing granulation technology, according to the preparation method in the text, using the same prescription of the present invention, to o...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a high-dispersity composition of low-dose drugs and a preparation method of the high-dispersity composition, aiming to solve the problem that existing preparation methods for the low-dose drugs cannot meet requirements on content uniformity and influences of parameter change amplification in the production process on physicochemical properties of the low-dose drugs are remarkable. The high-dispersity composition and the preparation method thereof have the advantages that the low-dose drugs are prepared by the twin-screw extrusion technology for the first time; Vitamin Danalogue drugs, glucocorticoid drugs, antipsychotics, antipyretic and analgesic drugs and other low-dose drugs are screened as research objects; preparation of solid preparations through a twin-screwextruder is studied deeply; the content uniformity meets requirements of the pharmacopeia.

Description

technical field [0001] The invention relates to a low-dose pharmaceutical composition and a preparation method thereof, in particular to a highly dispersed low-dose pharmaceutical composition and a preparation method thereof, belonging to the technical field of pharmaceutical preparation. Background technique [0002] Low-dose pharmaceutical preparations refer to solid pharmaceutical preparations such as tablets, capsules, granules, and sprays with a single labeled dose of no more than 1 mg. Due to its extremely low unit drug content, it is extremely vulnerable to loss and pollution during the production process; therefore, it requires highly sensitive analytical methods and extremely fine pre-treatment methods in the preparation process, and obtains a good recovery rate; in addition, the final The content uniformity of the product and the stability requirements of the product in production and storage are relatively high. For low-dose pharmaceutical preparations, its formu...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/16A61J3/00A61K31/59
CPCA61J3/00A61K9/1682A61K31/59
Inventor 包玉胜马冲陶莉袁晓丽郑慧娟闵涛
Owner NANJING HERON PHARM CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap